Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast versus slow intravenous tramadol for postoperative nausea and vomiting
ACTRN12606000201572Phase 4Not yet recruiting
- Sponsor
- ANZCA
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tramadol in postoperative pain and postoperative nausea and vomiting (PONV), sponsored by ANZCA. Primary endpoint: Comparative peak change from baseline in nausea visual analogue score. Planned start Jul 2006; status: not yet recruiting.
02
Drugs
tramadol
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ACTRN12606000201572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000201572.